Showing 35,646 results

Starting treatment

Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA in Treatment-Naïve Adults with HIV-1

Editor's pick
Janssen press release
1 November 2018
Starting treatment

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
1 November 2018
The search for a cure

STEPS V: HIV cure community workshop in Glasgow

Editor's pick
EATG
1 November 2018
Mental & emotional health problems

Experts: Don't Overlook Mental Health in People Living With HIV

Editor's pick
Medpage Today
1 November 2018
HIV & criminal law

Man who infected two women with HIV and ‘took coward’s way out’ is jailed

Editor's pick
Metro
1 November 2018
Chemsex & recreational drug use

This Is How The Justice System Is Trying To Stop The Chemsex Crimewave

Editor's pick
BuzzFeed
1 November 2018
Starting treatment

Dolutegravir or lower-dose efavirenz equally effective, but less resistance with dolutegravir

News
1 November 2018
Bad science & bogus treatments

'No cure' for HIV in Zimbabwe says UN, following claims from local preacher

Editor's pick
UN News
1 November 2018
Vaginal rings & topical PrEP

Going local – prevention conference hears about rings, douches, and soluble suppositories

News
31 October 2018
Injectable & long-acting PrEP

Beyond Truvada – what is the future of PrEP?

News
31 October 2018
Starting treatment

Bictegravir matches dolutegravir in first-line treatment

News
31 October 2018
New & experimental HIV treatments

Long-lasting HIV injection is a step closer after second GSK study

Editor's pick
Reuters
31 October 2018
Transgender people

Substantial gaps in PrEP care continuum for trans women in San Francisco

News
30 October 2018
Child developmental issues

Neural tube defects and integrase inhibitors: studies show no further evidence of increased risk

News
30 October 2018
Treatment simplification strategies

Two-drug protease inhibitor treatment as effective as three-drug treatment – and fewer stop due to side-effects

News
30 October 2018
PrEP science

Boston HIV clinic sees 90% reduction in infections in people being prescribed PrEP

News
30 October 2018
Money

What it’s like to provide HIV care to people without housing

Editor's pick
BETA blog
29 October 2018
TB transmission & prevention

49th Union World Conference on Lung Health: First promising TB vaccine candidate in 100 years needs more resources, researchers say

Editor's pick
Science Speaks
29 October 2018
Conference announcements & declarations

An Open Letter From Your AIDS 2020 Conference Coordinating Committee

Editor's pick
Poz
29 October 2018
Epidemiology

HPTN 075 study demonstrates high rate of HIV infection among African MSM and TGW

Editor's pick
Eurekalert Inf Dis
29 October 2018
People & personal stories

A Doctor Who Died In The Pittsburgh Shooting Is Being Remembered As A Hero To Patients During The AIDS Crisis

Editor's pick
Buzzfeed News
29 October 2018
PrEP programmes & uptake

PrEP providers and communicators should stop talking about ‘risk’

News
29 October 2018
Transgender people

Rolling back transgender protections would endanger patients, experts say

Editor's pick
Healio
29 October 2018
PrEP programmes & uptake

PrEP: The battle against stigma

Editor's pick
GMFA
29 October 2018